Abstract
To assess the morphological changes due to pyridostigmine (Pyr), sublethal doses of Pyr (20 and 40 mg/ kg body weight) were given to adult rats through a gastric tube. Within 24 h, acute focal necroses, leukocytic infiltrates and marked changes in the motor endplates appeared in the skeletal muscle. The changes were more evident in the diaphragm than in the quadriceps muscle. The acetylcholinesterase activity in the whole blood and in the erythrocytes was reduced to considerably less than onehalf of the normal value.
The histological changes induced by Pyr have not been reported to date, but are similar to those observed in experimental poisoning with other anticholinesterase agents such as carbamates and organophosphates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Pyr:
-
Pyridostigimine
- ACh:
-
Acetylcholine
- AChE:
-
Acetylcholinesterase
References
Akaike A, Ikeda SR, Brookes N, Pascuzzo GJ, Rickett DL, Albuquerque EX (1984) The nature of the interactions of Pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. Mol Pharmacol 25: 102–112
Ariens ATh, Meeter E, Wolthuis OL, Van Benthem RMJ (1969) Reversible necrosis at the end-plate region in striated muscles of the rat poisoned with cholinesterase inhibitors. Experientia 25: 57–59
Berry WK, Davies DR (1970) The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem Pharmacol 19: 927–934
Busch WA, Stromer MH, Goll DE, Suzuki A (1972) Ca2+-specific removal of Z lines from rabbit skeletal muscle. J Cell Biol 52: 367–381
Chang HW, Neumann E (1976) Dynamic properties of isolated acetylcholine receptor proteins: Release of calcium ions caused by acetylcholine binding. Proc Natl Acad Sci USA 73: 3364–3368
Dettbarn W-D (1984) Pesticide induced muscle necrosis: Mechanisms and prevention. Fundament Appl Toxicol 4: S18-S26
Deyi X, Linxiu W, Shuqiu P (1981) The inhibition and protection of cholinesterase by Physostigmine and Pyridostigmine against Soman poisoning in vivo. Fundament Appl Toxicol 1: 217–221
Dirnhuber P, French MC, Green DM, Leadbeater L, Stratton JA (1979) The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol 31: 295–299
Feng H, Rogers AW, Salpeter MM (1973) Recovery of esterases at muscle endplates inactivated by DFP. J Cell Biol 59: 98a
Fenichel GM, Kibler WB, Olson WH, Dettbarn W-D (1972) Chronic inhibition of cholinesterase as a cause of myopathy. Neurology 22: 1026–1033
Fenichel GM, Dettbarn W-D, Newman TM (1974) An experimental myopathy secondary to excessive acetylcholine release. Neurology 24: 41–45
Fischer G (1968) Inhibierung und Restitution der Azetylcholinesterase an der motorischen Endplatte im Zwerchfell der Ratte nach Intoxikation mit Soman. Histochemie 16: 144–149
Fromherz K, Pellmont B (1953) Pharmakologische Wirkungen des MESTINON “Roche” (Dimethylcarbaminsäureester des 1-Methyl-3-oxypyridinium-bromid; Pyridostigmin-bromid). Schweiz Med Wschr 49: 1187–1190
Gall D (1981) The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundament Appl Toxicol 214–216
Gordon JJ, Leadbeater L, Maidment MP (1978) The protection of animals against organophosphate poisoning by pretreatment with carbamate. Toxicol Appl Pharmacol 43: 207–216
Harris LW, Stitcher DL, Heyl WC (1981) Protection and induced reactivation of cholinestrase by HS-6 in rabbits exposed to soman. Life Sci 29: 1747–1753
Harris LW, Lennox WJ, Talbot BG (1984) Toxicity of anticholinesterases: Interactions of pyridostigmine and physostigmine with Soman. Drug Chem Toxicol 7: 507–526
Kawabuchi M (1982) Neostigmine myopathy is a calcium ion-mediated myopathy initially affecting the motor end-plate. J Neuropathol Exp Neurol 41: 298–314
Kawabuchi M, Osame M, Watanabe S, Igata A, Kanaseki T (1976) Myopathic changes at the end-plate region induced by neostigmine methylsulfate. Experientia 32: 623–625
Laiho KU, Berezesky IK, Trump BF (1983) The role of calcium in cell injury. Studies in Ehrlich ascites tumor following injury with anoxia and organic mercurials. Surv Synth Path Res 2: 170–183
Laskowski MB, Olson WH, Dettbarn W-D (1975) Ultrastructural changes at the motor end-plate produced by an irreversible cholinesterase inhibitor. Exp Neurol 47: 290–306
Laskowski MB, Olson WH, Dettbarn W-D (1977) Initial ultrastructural abnormalities at the motor end plate produced by a cholinesterase inhibitor. Exp Neurol 57: 13–33
Leonard J, Salpeter MM (1979) Agonist induced myopathy at the neuromuscular junction is mediated by calcium. J Cell Biol 82: 811–819
Marx JL (1984) A new view of receptor action. Science 224: 271–274
Mittelbach F, Pongratz D (1968) Behandlung des myasthenischen Syndroms mit Mestinon retard. Münch Med Wschr 110: 1375–1380
Neugebauer J, Morant J (1985) Mestinon®. Arzneimittel-Kompendium der Schweiz. Documed, Basel p 851
Osame M, Kawabuchi M, Igata A, Sugita H (1975) Experimental nemaline rods induced by anticholinesterase drug (neostigmine methylsulfate). Proc Jpn Acad 51: 598–603
Pascuzzo GJ, Akaike A, Maleque MA, Shaw K-P, Aronstam RS, Rickett DL, Albuquerque EX (1984) The nature of the interaction of pyridostigmine with nicotinic acetylcholine receptor-ionic channel complex. Mol Pharmacol 25: 92–101
Preusser H-J (1967) Die Ultrastruktur der motorischen Endplatte im Zwerchfell der Ratte und Veränderungen nach Inhibierung der Acetylcholinesterase. Z Zellforsch 80: 436–457
Rális HM, Beesley RA, Rális ZA (1973) Techniques in neurohistology. Butterworths, London-Sydney-Toronto-Wellington-Durban, pp 142–143
Reddy MK, Etlinger JD, Rabinowitz M, Fischman DA, Zak R (1975) Removal of Z-lines and alpha-actinin from isolated myofibrils by a calcium-activated neutral protease. J Biol Chem 250: 4278–4284
Rübsamen H, Hess GP, Eldefrawi AT, Eldefrawi ME (1976) Interaction between calcium and ligand-binding sites of the purified acetylcholine receptor studied by use of a fluorescent lanthanide. Biochem Biophys Res Commun 68: 56–63
Salpeter MM, Kasprzak H, Feng H, Fertuck H (1979) Endplates after esterase inactivation in vivo: correlation between esterase concentration, functional response and fine structure. J Neurocytol 8: 95–115
Schulman H (1984) Calcium dependent protein kinases and neurinal function. TIPS 5: 188–192
Tóth L, Karcsu S, Poberai M, Sávay G (1983) Histochemical evidence for the role of Ca2+ and neutral protease in the development of the subacute myopathy induced by organophosphorous compounds. Acta histochem 72: 71–75
Voss G, Sachsse K (1970) Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine/DTNB procedure. Toxicol Appl Pharmacol 16: 764–772
Wilson IB, Hatch MA, Ginsburg S (1960) Carbamylation of acetylcholinesterase. J Biol Chem 235: 2312–2315
Wilson IB, Harrison MA, Ginsburg S (1961) Carbamyl derivatives of acetylcholinesterase. J Biol Chem 236: 1498–1500
Yamaguchi M, Robson RM, Stromer MH, Cholvin NR, Izumimoto M (1983) Properties of soleus muscle Z-lines and induced Z-line analogs revealed by dissection with Ca2+-activated neutral protease. Anat Rec 206: 345–362
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gebbers, J.O., Lötscher, M., Kobel, W. et al. Acute toxicity of pyridostigmine in rats: histological findings. Arch Toxicol 58, 271–275 (1986). https://doi.org/10.1007/BF00297119
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00297119